INNOCARE PHARMA LTD revenue for the last year amounted to 812.49 M HKD, the most of which — 816.08 M HKD — came from its highest performing source at the moment, Biopharmaceutical Research and Development, Manufacturing, Commercialization and Services, the year earlier bringing 727.27 M HKD. The greatest contribution to the revenue figure was made by China — last year it brought INNOCARE PHARMA LTD 743.81 M HKD, and the year before that — 660.56 M HKD.